Enhanced entertopathogen detection among HIV-infected patients with diarrhea by multiplex PCR.

APACC 2020

Prevalence of Hepatitis B and Hepatitis C Infection and Their Associated Factors Among HIV-Infected Individuals in Same-Day Antiretroviral Therapy Initiation Program in Bangkok, Thailand

APACC 2020

HIV-infected Clients Still had Significantly Higher Prevalence of Hepatitis B Infection than HIV-Uninfected Individuals Receiving Services at the Thai Red Cross Anonymous Clinic, Bangkok, Thailand

APACC 2020

Changing patterns of sex networking and sexually transmitted infection in HIV-positive men who have sex with men following HIV diagnosis

APACC 2020

Seroprevalence and factors associated with hepatitis B infection among the hill tribe adult population in Thailand: a cross-sectional study

APACC 2020

The Clinical Presentation and Factors Associated with Mortality of HIV-infected patients with neurologic manifestation in Indonesia: a prospective study

APACC 2020

Change of seroconversion rate after vaccination with Aimmugen® among MSM.

APACC 2020

Retention in the HCV Care Cascade for People living with HIV in Delhi and Manipur, India and Malaysia: The HEAD-Start Project

APACC 2020

Screening and treatment of latent tuberculosis infection among people living with HIV in the era of antiretroviral therapy scale-up

APACC 2020

Compliance to Hepatitis B Vaccination Guidelines and Development of Seroprotection in Filipino Hepatitis B Susceptible HIV Patients in a Tertiary Hospital Treatment HUB

APACC 2020

Drug Resistance to Novel Non-Nucleoside Reverse Transcriptase Inhibitor Elsulfavirine Among Treatment-Naïve, HIV-Infected Caucasian and Asian Patients

APACC 2020

Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the Gemini Studies in Participants From Asian Centres

APACC 2020

Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Adults Living With HIV

APACC 2020

Efficacy and Safety of Switching to B/F/TAF in Virologically Suppressed Asian Women Living With HIV

APACC 2020

Assessment of the Safety of Dolutegravir in HIV-Infected Patients From China: A Real-World, Open-Label, Multicenter, Post-Marketing Surveillance Study

APACC 2020

Treatment Persistence Among HIV-1 Patients Initiating Antiretroviral Therapy in Japan

APACC 2020

Pooled Analysis of the Efficacy, Safety, and Health Outcomes Following 48 Weeks of Long-acting Cabotegravir and Rilpivirine Maintenance Therapy for HIV-1 Infection in Phase 3 ATLAS and FLAIR Studies: Sub-Analysis in Asian Populations

APACC 2020

Safety and Efficacy of Genvoya® (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide, EVG/C/F/TAF) From the 3rd Year Post Market Surveillance (PMS) Data in Korea

APACC 2020

The Impact of Gender on the Clinical Course of HIV Infection in Yangon, Myanmar

APACC 2020

Anti-Müllerian Hormone Levels and Related Factors of 715 HIV-Infected Women in Childbearing Age

APACC 2020

Analysis of Total HIV-1DNA in Peripheral Blood After HAART in HIV-1/ Hcv Co-Infected Patients

APACC 2020

Switch-Rate and Switch-Pattern of Patients on 2-Drug Antiretroviral Treatment – Comparison to 3-Drug Regimen in a Japanese Hospital Claim Database

APACC 2020

The Changes of Health-Related Quality-of-Life and Sleep Quality Following the Switch of Anti- Retroviral Treatment in Patients with Well-Controlled HIV Infection

APACC 2020

Factors Associated With High Alanine Aminotransferase (ALT) and Cirrhosis in People Living With HIV on Combination Antiretroviral Treatment (cART) in the Asia-Pacific

APACC 2020